T Cell Response to Dengue Virus
T Cell Response to Dengue Virus
批准号:
7477343
负责人:
Sujan Shresta
金额:
$23.18万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2009-08-31
关键词:
Adoptive TransferAnimal ModelAntibodiesAntibody FormationArthropodsB-LymphocytesBiological AssayCD4 Positive T LymphocytesCD8B1 geneCategoriesCessation of lifeClassificationClinicalCollaborationsCulicidaeDataDatabasesDengueDengue Hemorrhagic FeverDengue Shock SyndromeDengue VirusDevelopmentDiseaseDissectionEconomicsElementsEpidemiologic StudiesEpitopesFlavivirusFlow CytometryFoundationsGoalsHeadHistologicHumanImmuneImmune responseImmune systemImmunityImmunoglobulin GImmunoglobulin MInbred MouseInfectionInvestigationLaboratoriesLeadLyticMeasuresMediatingMethodsModelingMonitorMusNational Institute of Allergy and Infectious DiseasePathogenesisPeptide/MHC ComplexPlayProductionResearchRoleSecondary toSerotypingStandards of Weights and MeasuresSystemT-Cell ProliferationT-LymphocyteT-Lymphocyte EpitopesT-Lymphocyte SubsetsTestingVaccinesVariantViralVirusVirus DiseasesWild Type Mousebasecostcytokinecytotoxicitydisease phenotypeenzyme linked immunospot assaygain of functionhuman diseaseimmunopathologyin vivoloss of functionmembermouse modelnovelpathogenpositional cloningresponsevaccine evaluation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dengue virus (DEN) causes dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), the most prevalent arthropod-borne viral illnesses in humans worldwide. Studies suggest that DHF/DSS is an immunopathogenic disease in which the T cell-mediated immune system may be dysregulated. However, the precise role of the T cell-dependent immunity in response to DEN infection in vivo is not fully defined due to the lack of an adequate animal model that allows dissection of the adaptive immune response. Our long-term goal is to elucidate how the immune system interacts with DEN in vivo and then develop a mouse model of DHF/DSS. In this proposal, we will test the hypothesis that T cells play a protective role in the host response to DEN. Specifically, we will characterize the T cell response to primary DEN infection in mice by monitoring T cell proliferation and differentiation and by identifying the DEN epitopes recognized by CD4+ and CD8+ T cells (Aim 1). Next, we will determine whether T cells can protect against primary DEN infection using a variety of loss-of-function and gain-of-function models for mouse T cells in combination with newly generated DEN strains that cause disease in 100% of T and B cell-deficient mice, and are nonvirulent in wild-type mice (Aim 2). Overall, this research will elucidate the cellular mechanisms of the immune response to primary DEN infection in vivo and establish the foundation for elucidating the protective versus pathogenic mechanisms of the immune system in primary and sequential DEN infections.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.1001709
发表时间:
2010-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, Sette A, Shresta S]
通讯作者:
Shresta S
Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis
-
批准号:10366012
-
项目类别:
-
资助金额:$72.54万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Development of a Replicon RNA-based Vaccine against Dengue and Zika
-
批准号:10413253
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis
-
批准号:10212141
-
项目类别:
-
资助金额:$72.54万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis
-
批准号:10581624
-
项目类别:
-
资助金额:$56.84万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Development of a Replicon RNA-based Vaccine against Dengue and Zika
-
批准号:10281127
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Development of a Replicon RNA-based Vaccine against Dengue and Zika
-
批准号:10626835
-
项目类别:
-
资助金额:$72.18万
-
财政年份:2021
-
负责人:Sujan Shresta
-
依托单位:
Targeting Angiogenesis Pathways for Therapeutic Protection against Dengue
-
批准号:9223436
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2017
-
负责人:Sujan Shresta
-
依托单位:
IRF-3/5/7-Independent Antiviral Immunity
-
批准号:9029196
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2016
-
负责人:Sujan Shresta
-
依托单位:
T cell response to Dengue virus serotype 3 in mice and humans
-
批准号:8375880
-
项目类别:
-
资助金额:$40.69万
-
财政年份:2012
-
负责人:Sujan Shresta
-
依托单位:
T cell response to Dengue virus serotype 3 in mice and humans
-
批准号:8234188
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2011
-
负责人:Sujan Shresta
-
依托单位:
Pathogenic Role of Antibodies to Dengue Virus
-
批准号:8295069
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:Sujan Shresta
-
依托单位:
T cell response to Dengue virus serotype 3 in mice and humans
-
批准号:7671900
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2009
-
负责人:Sujan Shresta
-
依托单位:
T Cell Response to Dengue Virus
-
批准号:7392893
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2007
-
负责人:Sujan Shresta
-
依托单位:
T cell response to Dengue virus serotype 3 in mice and humans
-
批准号:8437250
-
项目类别:
-
资助金额:$44.06万
-
财政年份:--
-
负责人:Sujan Shresta
-
依托单位:
T cell response to Dengue virus serotype 3 in mice and humans
-
批准号:8036025
-
项目类别:
-
资助金额:$45.87万
-
财政年份:--
-
负责人:Sujan Shresta
-
依托单位:
海外基金